Pramipexole Dihydrochloride Tablet
Product Images NDC 68462-331

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 68462-331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 0 125 mg

Bottle Label 0 125 mg
This is a description of a medication called Pramipexole Dihydrochloride which comes in 90 tablets of 0.125mg. The National Drug Code (NDC) for this medication is 68462-330-90, and it is manufactured by Glenmark Pharmaceuticals. There are several lines of unrelated text which seem to be errors.*
FDA Label Image

Bottle Label 0 25 mg

FDA Label Image

Bottle Label 0 5 mg

FDA Label Image

Bottle Label 1 mg

FDA Label Image

Bttl Label1 5mg

Bttl Label1 5mg
This is a description for Pramipexole Dihydrochloride Tablets, manufactured by Glenmark. The tablets come in a bottle of 90 and they are only sold with a prescription. Unfortunately, the rest of the text seems to be garbled and not readable.*
FDA Label Image

Chemical Structure

FDA Label Image

Logo 01

FDA Label Image
FDA Label Image

Pramipexole-75 (Pramipexole 75)

Pramipexole-75 (Pramipexole 75)
Each tablet of this medication contains 0.75 mg of pramipexele dihydrochloride monohydrate. It is important to read the accompanying prescribing information for dosage. The tablets should be dispensed in a tight, light-resistant container and stored between 20-25°C (68-77°F), with excursions permitted to 15-30°C (9-86°F). They should be protected from light, and kept out of the reach of children. This medication is manufactured by Glenmark Pharmaceuticals Ltd. and dispensed with patient information sheet provided separately. For further information, contact 1 (8887217115) or visit wuniglenmarkpharmacomius.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.